Hungarian Psychedelic Association
The registration of the association in the official register is currently underway. Our website is also currently under development.
Current Projects & Updates
Here we regularly share updates on our current projects, events, research initiatives, and publications.
On this page, you will find news about our work, reports on ongoing programs, information about collaborations, and summaries of relevant studies and research findings in the field of psychedelic science.
Our goal is to make knowledge accessible, promote scientific dialogue, and keep the public informed about new developments, discoveries, and activities of the Psychedelic Society.
We invite you to visit regularly and stay up to date with our latest news and updates.
.png)
.png)
11
10
Nicotine Withdrawal: High-Dose Psilocybin Supports Psychotherapy More Effectively Than Nicotine Patches – News Article, Deutsches Ärzteblatt
Psilocybin vs. Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial – JAMA Network Open, Substance Use and Addiction Medicine (JAMA Network)
08
Working to ensure the safety of the psychedelic community: present at 311 parties and festivals, supported by more than 50 active volunteers and several hundred former volunteers.
07
Daath and SELVA Talks are pleased to invite you to the Hungarian Psychedelic Conference.
The process often referred to as the “psychedelic renaissance” has accelerated remarkably worldwide since the mid-2010s. While the approval of MDMA as a medical treatment is still pending in many regions, psilocybin-assisted therapies, ketamine clinics, ayahuasca retreats, and psychedelic therapist training programs have already become accessible in numerous countries.
Despite limited political, economic, and social opportunities, Hungary is also part of these developments. Although human resources remain limited, the country maintains valuable connections with the international psychedelic community and research landscape.
The Second Hungarian Psychedelic Conference aims to provide a broad overview of the current state of psychedelic research, practice, and community initiatives in Hungary. Through this scientific, cultural, and community-oriented event, participants will gain insight into ongoing activities, current developments, and future perspectives within the field.
06
As part of our collaboration with PSI Pain Clinic, we support professional exchange in the field of ketamine-assisted therapy. Current scientific evidence suggests that ketamine, when administered under controlled medical conditions, may offer a promising treatment option for individuals with treatment-resistant depression. Together, we are committed to evidence-based education, research, and the responsible development of therapeutic applications.
05
Here is a current overview of the situation in Switzerland:
04
In Norway, ketamine is currently the subject of intense discussion, primarily due to the high costs associated with treatment.
03
The book Psychedelic Harm Reduction, edited by Tomislav Majic, was recently published.
02
In collaboration with the Association for Integrative Therapy e.V., we promote professional exchange in the fields of evidence-based psychotherapy, therapeutic innovation, and integrative treatment approaches. The partnership aims to connect professionals, support scientific collaboration, and contribute to the development of modern and responsible approaches to mental health care.
.png)
01